About Trinity Biotech
Trinity Biotech is a company based in Bray (Ireland) founded in 1992. The company has 401 employees as of December 31, 2024. Trinity Biotech has completed 3 acquisitions, including EpiCapture, Lab21 and iMMCO Diagnostics. Trinity Biotech offers products and services including Premier Resolution, Bartels FlexTrans Transport Medium, and Uni-Gold HIV Complete.
- Headquarter Bray, Ireland
- Employees 401 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Trinity Biotech Plc Sponsored Adr Class A
-
Annual Revenue
$61.55 M (USD)8.31as on Dec 31, 2024
-
Net Profit
-$31.79 M (USD)-32.35as on Dec 31, 2024
-
EBITDA
-$9.68 M (USD)28.24as on Dec 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
401
as on Dec 31, 2024
-
Investments & Acquisitions
EpiCapture
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Trinity Biotech
Trinity Biotech is a publicly listed company on the NASDAQ with ticker symbol TRIB in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Trinity Biotech
Trinity Biotech offers a comprehensive portfolio of products and services, including Premier Resolution, Bartels FlexTrans Transport Medium, and Uni-Gold HIV Complete.
Device for detecting thalassemia and haemoglobin variants in diagnostics.
Medium to suppress contamination during specimen transport.
Test for rapid detection of HIV antibodies in blood samples.
People of Trinity Biotech
Unlock access to complete
Software Development Team
16 people
Leadership Team
7 people
Sales and Marketing
7 people
Finance and Accounting
6 people
Product Management Team
5 people
Operations Team
4 people
Field Team
2 people
Regulatory Team
1 people
Unlock access to complete
Funding Insights of Trinity Biotech
Investors in Trinity Biotech
Trinity Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include MICO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer and supplier of brake systems and hydraulic components
|
Locked | Locked | Locked |
Investor details for Trinity Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Trinity Biotech
Trinity Biotech has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include EpiCapture, Lab21 and iMMCO Diagnostics.
Investment portfolio details for Trinity Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Non-invasive liquid tests for cancer detection are developed.
|
Locked | Locked | 2021 | Locked | |
|
Personalised diagnostic testing for diseases and predisposition is specialised in.
|
Locked | Locked | 2005 | Locked | |
|
Diagnostic solutions for autoimmune disorders are developed and distributed.
|
Locked | Locked | 1971 | Locked |
Complete acquisition details for Trinity Biotech
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Trinity Biotech
Detailed financials for Trinity Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Trinity Biotech Comparisons
Peer comparison for Trinity Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Trinity Biotech
Detailed competitors of Trinity Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Trinity Biotech
Complete news archive for Trinity Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Trinity Biotech
Trinity Biotech was founded in 1992 and raised its 1st funding round 23 years after it was founded.
Trinity Biotech is headquartered in Bray, Ireland. It is registered at Bray, Wicklow, Ireland.
As of Dec 31, 2024, the latest employee count at Trinity Biotech is 401.
Annual revenue of Trinity Biotech is $61.55M as on Dec 31, 2024.
Trinity Biotech develops in vitro diagnostic kits for clinical labs. The company provides assay kits for infectious diseases, hematology, autoimmune diseases, critical care, urine tests and other assays based on clinical chemistry, In addition, it also provides rapid point-of-care assay kits for HIV, sexual health, respiratory infections, and a POC analyzer called Meritas that runs the assays. It also offers portable HbA1c analyzer.
Trinity Biotech offers Premier Resolution, Bartels FlexTrans Transport Medium, and Uni-Gold HIV Complete.
Yes, Trinity Biotech is publicly traded on NASDAQ under the ticker symbol TRIB.
Trinity Biotech has made 3 acquisitions, including EpiCapture, Lab21, and iMMCO Diagnostics.
Trinity Biotech has 1 investor. Key investors include MICO.
The ticker symbol of Trinity Biotech is TRIB on NASDAQ.